Today: 14 June 2026
Browse Category

NASDAQ:EVCM 14 December 2025 - 19 December 2025

EverCommerce (EVCM) Stock Today: Why Shares Are Sliding on Dec. 19, 2025 as Insider Sales, AI Strategy, and Analyst Forecasts Collide

EverCommerce (EVCM) Stock Today: Why Shares Are Sliding on Dec. 19, 2025 as Insider Sales, AI Strategy, and Analyst Forecasts Collide

EverCommerce Inc. shares fell about 5%–6% to near $12 in afternoon trading on December 19, 2025, following a recent spike to a 52-week high around $14.41 earlier in the week. The drop comes amid heavy volatility, insider selling disclosures from top executives, and continued focus on the company’s shift toward AI-driven SaaS.
19 December 2025
··

Stock Market Today

  • Indivior's Chief Scientific Officer Sells Shares Amid Stock Rally: Investor Implications
    June 14, 2026, 12:02 AM EDT. Christian Heidbreder, Chief Scientific Officer at Indivior Pharmaceuticals, sold 18,586 shares valued at $707,383 on June 11, 2026, representing 7.54% of his holdings. Post-sale, he retains 227,923 shares worth about $8.69 million, maintaining a 0.18% stake. The sale occurred during a significant stock price surge, with Indivior shares rising 177% over the past year, reflecting strong market performance amid growth in opioid dependence therapies. The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan, not signaling insider concerns. Indivior's strategy focuses on buprenorphine-based addiction treatments, with $1.29 billion in trailing twelve-month revenue and $252 million net income, underscoring its established market position and ongoing research-led expansion.

Latest articles

Kraft Heinz Shares Rally for Six Days—Is KHC a Buy Now?

Kraft Heinz Shares Rally for Six Days—Is KHC a Buy Now?

14 June 2026
Kraft Heinz closed up 0.70% at $24.39, outpacing the S&P 500, as investors weighed its 6.6% dividend yield against falling organic sales, lower adjusted earnings, and cautious analyst targets; the next earnings update is seen as the key test for whether $600 million in marketing and R&D can revive growth and support the stock’s rebound.
Go toTop